1 |
Smith SC. Need for a paradigm shift : The importance of risk factor reduction therapy in treating patients with cardiovascular disease. Am J Cardiol 1998;82:10-3
DOI
ScienceOn
|
2 |
Welsh GN, Loscalzo J. Mechanism of disease : homocysteine and atherothrombosis. N Engl J Med 1998;338:1042-50
DOI
ScienceOn
|
3 |
Hopkins PN, Hunt SC, Wu LL, Williams GH, Williams RR. Hypertension, dyslipidemia, and insulin resistance : links in a chain or spokes on a wheel? Curr Opin Lipidol 1996;7: 241-53
DOI
ScienceOn
|
4 |
Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl Med 1996;334:374-81
DOI
ScienceOn
|
5 |
Eikelboom JW, Lonn E, Genest J, Hankey G, Yusuf S. Homocysteine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999;131: 363-75
DOI
ScienceOn
|
6 |
Malinow MR, Bostom AG, Krauss RH. Homocysteine, diet, and cardiovascular diseases : a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1999;99:178-82
DOI
ScienceOn
|
7 |
Osganian SK, Stampfer MJ, Spiegelman O, Rimm E, Cutler JA, Feldman DH, et al. Distribution of and factors associated with serum homocysteine levels in children : child and adolescent trial for cardiovascular health. JAMA 1999; 281:1189-96
DOI
ScienceOn
|
8 |
Henning BF, Tepel M, Riezler R, Gillessen A, Doberauer C. Vitamin supplementation during weight reduction-favourable effect on homocysteine metabolism. Res Exp Med 1998;198:37-42
DOI
ScienceOn
|
9 |
Selhub J. Homocysteine metabolism. Annu Rev Nutr 1999; 19:217-26
DOI
ScienceOn
|
10 |
Dixon JB, Dixon ME, O'Brien PE. Elevated homocysteine levels with weight loss after Lap-Band surgery : higher folate and vitamin B12 levels required to maintain homocysteine level. Int J Obesity 2001;25:219-27
DOI
ScienceOn
|
11 |
Landgren F, Israelsson B, Lindgren A, Hultberg B, Andersson A, Brattstrom L. Plasma homocysteine in acute myocardial infarction : homocysteine lowering effect of folic acid. J Intern Med 1995;237:381-8
DOI
ScienceOn
|
12 |
Guba SC, Fink LM, Fonseca V. Hyperhomocysteinemia : An emerging and important risk factor for thromboembolic and cardiovascular disease. Am J Clin Pathol 1996;106:709-22
DOI
|
13 |
Tonstad S, Refsum H, Sivertsen M, Christophersen B, Ose L, Ueland PM. Relation of total homocysteine and lipid levels in children to premature cardiovascular death in male relatives. Pediatr Res 1996;40:47-52
DOI
|
14 |
Chambers JC, McGregor A, Jean-Marie J, Kooner JS. Acute hyperhomocysteinaemia and endothelial dysfunction. Lancet 1998;351:36-7
|
15 |
Pietrobelli A, Faith MS, Allison DB, Gallagber D, Chiumello G, Heymsfield SB. Body mass index as a measure of adiposity among children and adolescents; A validation study. J Pediatr 1998;132:204-10
DOI
ScienceOn
|
16 |
Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeiter P. Increased incidence of non-insulindependent diabetes mellitus among adolescents. J Pediatr 1996;128:608-15
DOI
ScienceOn
|
17 |
Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, et al. Globular adiponectin protected ob/ob mice from diabetes and apoE deficient mice from atherosclerosis. J Biol Chem 2003;278:2461-8
DOI
ScienceOn
|
18 |
Moghadasian MH, McManus BM, Frohlich JJ. Homocysteine and coronary artery disease. Arch Intern Med 1997; 157:2299-308
DOI
|
19 |
Rocchihi AP. Insulin resistance, obesity and hypertension. J Nutr 1995;125:1718S-24S
|
20 |
Standley PR, Bakir MH, Sowers JR. Vascular insulin abnormalities, hypertension, and accelerated atherosclerosis. Am J Kidney Dis 1993;21:39-46
DOI
|
21 |
Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-57
DOI
|
22 |
Lakka HM, Lakka TA, Toumilehto J, Sivenius J, Salonen JT. Hyperinsulinemia and the risk of cardiovascular death and acute coronary and cerebrovascular events in men : The Kuopio ischaemic heart disease risk factor study. Arch Intern Med 2000;160:1160-8
DOI
ScienceOn
|
23 |
Schonfeld-Warden N, Warden CH. Pediatric obesity : An overview of etiology and treatment. Pediatr Clin North Am 1997;44:339-60
DOI
|
24 |
Cho SJ, Park SJ, Hwang IT, Hong YM. Risk factors for cardiovascular disease in obese children. J Korean Pediatr Soc 2001;44:493-500
|
25 |
Rimm EB, Willett W, Hu FB, Sampson L, Colditz GA, Mason JE, et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary artery disease among women. JAMA 1998;279:359-64
DOI
ScienceOn
|
26 |
De Leat C, Wautrecht JC, Brasseur D, Dramaix M, Boeynaems JM, Decuyper J, et al. Plasma homocysteine concentration in a Belgian school-age population. Am J Clin Nutr 1999;69:968-72
DOI
|
27 |
Greenlund KJ, Srinvasan SR Xu JH, Dalferes E, Myers L, Pickoff A, et al. Plasma homocysteine distribution and its association with parental history of coronary artery disease in black and white children; the Bogalusa Heart Study. Circulation 1999;99:2144-9
DOI
ScienceOn
|